Related Experiment Video
Updated: Aug 6, 2026

13:45
Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
10.2K
Merkel Cell Carcinoma: A Description of 11 Cases
E García-Zamora1, M Vela Ganuza1, J Martín-Alcalde1
1Dermatología, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España.
Actas Dermo-Sifiliograficas
|September 5, 2020
Summary
Merkel cell carcinoma (MCC) is a rare neuroendocrine tumor often diagnosed at advanced stages. This study found a high mortality rate, with 54% of patients dying from MCC within months of diagnosis.
Area of Science:
- Oncology
- Dermatology
- Pathology
Background:
- Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer.
- Metastasis and lymph node involvement are frequently observed at the time of diagnosis.
- Early detection and treatment are crucial for improving patient outcomes.
Observation:
- A retrospective study analyzed 11 MCC cases diagnosed between 1998 and 2018.
- 45% of patients presented with stage IIIB disease.
- Lymphovascular invasion was present in 7 cases, and 54% of patients died from MCC.
Findings:
- The study observed an MCC incidence rate similar to established epidemiological data.
- Local surgery was the primary treatment, often followed by adjuvant radiation or chemotherapy.
- The mean survival time for deceased patients was 14.5 months.
Implications:
- MCC is an uncommon but aggressive malignancy with a poor prognosis.
- Adjuvant therapies may improve outcomes, but further research is needed.
- Emerging treatments like avelumab show promise for metastatic MCC.
More Related Videos
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...

